These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 10534312)
21. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes. Thijssen HH; Flinois JP; Beaune PH Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154 [TBL] [Abstract][Full Text] [Related]
22. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165 [TBL] [Abstract][Full Text] [Related]
23. Human cytochrome P-450 metabolism of retinals to retinoic acids. Zhang QY; Dunbar D; Kaminsky L Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373 [TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Fang J; McKay G; Song J; Remillrd A; Li X; Midha K Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183 [TBL] [Abstract][Full Text] [Related]
25. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. Venkatakrishnan K; von Moltke LL; Greenblatt DJ J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560 [TBL] [Abstract][Full Text] [Related]
26. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Chen H; Howald WN; Juchau MR Drug Metab Dispos; 2000 Mar; 28(3):315-22. PubMed ID: 10681376 [TBL] [Abstract][Full Text] [Related]
27. A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. Kawashiro T; Yamashita K; Zhao XJ; Koyama E; Tani M; Chiba K; Ishizaki T J Pharmacol Exp Ther; 1998 Sep; 286(3):1294-300. PubMed ID: 9732391 [TBL] [Abstract][Full Text] [Related]
29. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436. Ji HY; Lee HW; Kim HH; Choi JK; Lee HS Toxicol Lett; 2005 Jan; 155(1):103-14. PubMed ID: 15585365 [TBL] [Abstract][Full Text] [Related]
30. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. Störmer E; von Moltke LL; Shader RI; Greenblatt DJ Drug Metab Dispos; 2000 Oct; 28(10):1168-75. PubMed ID: 10997935 [TBL] [Abstract][Full Text] [Related]
31. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450. Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007 [TBL] [Abstract][Full Text] [Related]
32. Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Yamazaki H; Inoue K; Turvy CG; Guengerich FP; Shimada T Drug Metab Dispos; 1997 Feb; 25(2):168-74. PubMed ID: 9029047 [TBL] [Abstract][Full Text] [Related]
33. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs. Li J; Liu Y; Zhang JW; Wei H; Yang L Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956 [TBL] [Abstract][Full Text] [Related]
34. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes. Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358 [TBL] [Abstract][Full Text] [Related]
35. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation. Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998 [TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Yang SP; Raner GM Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189 [TBL] [Abstract][Full Text] [Related]
37. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off. Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086 [TBL] [Abstract][Full Text] [Related]
38. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602 [TBL] [Abstract][Full Text] [Related]
39. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537 [TBL] [Abstract][Full Text] [Related]
40. Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research. Masimirembwa CM; Otter C; Berg M; Jönsson M; Leidvik B; Jonsson E; Johansson T; Bäckman A; Edlund A; Andersson TB Drug Metab Dispos; 1999 Oct; 27(10):1117-22. PubMed ID: 10497136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]